Evaluation of diabetic retinopathy by fluorophotometry: European concerted action on ocular fluorometry

International Ophthalmology

Volumn 22, Issue 2, 1998, Pages 97-104

  Van Schaik, Hilderik J ^a   Benitez Del Castillo, José M ^b   Caubergh, Marie José ^c   Gobert, Ann ^d   Leite, Eugenio ^e   Moldow, Brigit ^f   Rosas, Vitor ^g   Van Best, Jaap A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Pharmacy Department   (Spain)

^c Transplantation Clinic   (Switzerland)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

^e University Clinic   (Portugal)

^f Department of Ophthalmology   (Denmark)

^g University Clinic   (Portugal)

Author keywords

Blood retinal barrier; Cornea; Diabetes mellitus; Fluorophotometry; Retinopathy

Indexed keywords

ADULT; ARTICLE; AUTOFLUORESCENCE; BLOOD EYE BARRIER; BLOOD RETINA BARRIER; CLINICAL TRIAL; DIABETIC RETINOPATHY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FLUOROPHOTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PERMEABILITY BARRIER;

BLOOD-AQUEOUS BARRIER; BLOOD-RETINAL BARRIER; CORNEA; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FLUORESCEIN; FLUOROPHOTOMETRY; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAVENOUS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0032321976     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006132908679     Document Type: Article

References (33)

1. Merimee TJ. Diabetic retinopathy: a synthesis of perspectives. N Engl J Med 1990; 322: 978-83.
2. Bayo J, Sola C, Garcia F, Latorre PM, Vazquez JA. Prevalence of non-insulin dependent diabetes mellitus in Lejona (Vizcaya, Spain). Med Clin 1993; 101: 609-12.
3. Meadows P. Variations of diabetes mellitus prevalence in general practice and its relation to deprivation. Diabet Med 1995; 12: 696-700.
4. Mesbah M, Chwalow AJ, Balkau B, Costaglida D, Vauzella-Kervroedan F, Eschwege E. Prevalence of non-insulin dependent diabetes as perceived by general practitioners in France. Rev Epidemiol Sante Publique 1995; 43: 225-30.
5. Pagano G, Bargero G, Vuolo A, Bruno G. Prevalence and clinical features of known type 2 diabetes in the elderly: a population based study. Diab Med 1994; 11: 475-9.
6. Vilbergsson S, Sigurdsson G, Sigvaldason H, Hreidarsson AB, Sigfusson N. Prevalence and incidence of NIDDM in Iceland: evidence for stable incidence among males and females 1967-1991 - the Reykjavik Study. Diabet Med 1997; 14: 491-98.
7. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984; 102: 527-32.
8. Diabetic Retinopathy Study Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 1976; 81: 383-96.
9. Diabetic Retinopathy Study Group. Photocoagulation treatment of proliferative diabetic retinopathy: The second report of the Diabetic Study Group findings. Ophthalmology 1978; 85: 82-106.
10. Diabetic Retinopathy Study Group. Four risk factors for severe visual loss in diabetic retinopathy: The third report from the Diabetic Study Group. Arch Ophthalmol 1979; 97: 654-5.
11. Hersh PS, Green WR, Thomas JJV. Tractional venous loops in diabetic retinopathy. Am J Ophthalmol 1981; 92: 661-71.
12. Sullivan P, Caldwell G, Alexander N, Kohner E. Long-term outcome after photocoagulation for proliferative diabetic retinopathy. Diabetic Med 1990; 7: 788-94.
13. Boot JP, Van Gerven JM, Van Best JA, Vrij L, Lemkes HHPJ, Oosterhuis JA. Blood retinal and blood aqueous barriers in diabetics by fluorophotometry. Doc Ophthalmol 1989; 71: 19-27.
14. Janiec S, Rzendkowski M, Bolek S. The relation between corneal autofluorescence, endothelial cell count and the severity of the diabetic retinopathy. Int Ophthalmol 1995; 18: 211-4.
15. Mori F, Ishiko S, Abiko T, Kitaya N, Kato Y, Kanno H, Yoshida A. Changes in corneal and lens autofluorescence and blood glucose levels in diabetics parameters of blood glucose control. Curr Eye Res 1997; 16: 534-8.
16. Stolwijk TR, Van Best JA, Oosterhuis JA, Swart W. Corneal autofluorescence: An indicator of diabetic retinopathy. Invest Ophthalmol Vis Sci 1992; 33: 92-7.
17. Stur M, Reitner A, Irsigler K. The correlation of results of vitreous fluorophotometry and fluorescein angiography in non-proliferative diabetic retinopathy. Retina 1988; 8: 50-4.
18. Van Gerven JM, Boot JP, Lemkes HHPJ, Van Best JA. Effect of morphological abnormalities on blood retinal barrier permeability in diabetic retinopathy. Doc Ophthalmol 1992; 80: 183-8.
19. The Diabetic Retinopathy Study Research Group. Report 7: A modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 1981; 21: 210-26.
20. Moss E, Meuer SM, Klein R, Hubbard LD, Brothers RJ, Klein BEK. Are seven standard photographic fields necessary for classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 1989; 30: 823-8.
21. The Diabetic Retinopathy Study Research Group. Report 8: Photocoagulation treatment of proliferative diabetic retinopathy: Clinical application of Diabatic Retinopathy Study (DRS) findings. Ophthalmology 1981; 88: 583-600.
22. Van Best JA, Kuppens EVMJ. Summary of studies on the blue-green autofluorescence and light transmission of the ocular lens. J Biomed Optics 1996; 1: 243-50.
23. Lohmann AM, Van Best JA, De Keizer RJW. Corneal metabolism and epithelial barrier function after cataract surgery and intraocular lens implantation; A fluorophotometric study. Int Ophthalmol 1996; 19: 225-33.
24. Zeimer RC, Noth JM. A new method of measuring in vivo lens transmittance and study of lens scatter, fluorescence and transmittance. Ophthalmic Res 1984; 6: 246-55.
25. Zeimer RC, Lim HK, Ogura Y. Evaluation of an objective method for the in vivo measurement of changes in light transmittance of the human crystalline lens. Exp Eye Res 1987; 45: 969-76.
26. Van Best JA, Benitez Del Castillo JM, Diestelhorst M, Heintz B, Leite EC, Liesenborghs L, Schalnus R. Diffusion coefficient through the blood aqueous barrier using a standard protocol. Br J Ophthalmol 1996; 80: 356-62.
27. Van Schaik HJ, Heintz B, Larsen M, Leite L, Rosas V, Schalnus R, Van Best JA. Permeability of the blood-retinal barrier in healthy humans. Graefes Arch Clin Exp Ophthalmol 1997; 235: 639-46.
28. Boets EPM, Van Best JA, Verhaegen A, Den Hartigh J. Determination of the molar absorption coefficient of fluorescein sodium. Exp Eye Res 1992; 54: 143-4.
29. Bursell S, Delori FC, Yoshida A, Parker JS, Collas GD, MeMeel JW. Vitreous fluorophotometric evaluation of diabetics. Invest Ophthalmol Vis Sci 1984; 25: 703-10.
30. Zar JH. Biostatistical Analysis. 2nd ed., Englewood Cliffs, New Jersey, USA, Prentice Hall International, 1984.
31. Uchida H, Brigatti L, Caprioli J. Detection of structural damage from glaucoma with confocal laser image analysis. Invest Ophthalmol Vis Sci 1996; 37: 2393-401.
32. Kalm H, Egertsen R, Blohme G. Non-stereo fundusphotography as a screening procedure for diabetic retinopathy among patients with type II diabetes compared with 60D enhanced slit-lamp examination. Acta Ophthalomol 1989; 67: 546-53.
33. Van Best JA, Docchio F. Simple, low-cost, portable corneal fluorometer for detection of the level of diabetic retinopathy. Appl Optics 1998 (in press).